Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients

Author： Calza Dr Leonardo Manfredi Roberto Chiodo Francesco

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.11, 2006-11, pp. : 1497-1516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients

By Harris Marianne

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 389-400

Informa Healthcare

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3379-3389

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Risk in Patients with HIV Infection: Impact of Antiretroviral Therapy

By Bente Magny Bergersen

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1971-1987

Adis International

Access to resources Recommend Favorite

Effects of Antiretroviral Therapy on Immunity in Patients Infected with HIV

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1015-1022

Bentham Science Publishers

Access to resources Recommend Favorite